Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study

Experimental Gerontology

Volumn 43, Issue 4, 2008, Pages 347-352

  Sturm, Gisela ^a   Kollerits, Barbara ^a   Neyer, Ulrich ^b   Ritz, Eberhard ^c   Kronenberg, Florian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Academic Teaching Hospital   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aging of kidney; Hyperuricemia; Kidney disease; Progression; Uric acid

Indexed keywords

URIC ACID;

ADULT; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INDEPENDENT VARIABLE; KIDNEY FAILURE; KIDNEY HYPERTROPHY; KIDNEY MASS; MAJOR CLINICAL STUDY; MALE; NEPHRON; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RISK FACTOR; ULTRAFILTRATION; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CREATININE; DISEASE PROGRESSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS; URIC ACID;

EID: 40649109031     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.01.006     Document Type: Article

References (39)

1. Anderson S., and Brenner B.M. Progressive renal disease: a disorder of adaptation. Q. J. Med. 70 (1989) 185-189
2. Bo S., Cavallo-Perin P., Gentile L., Repetti E., and Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur. J. Clin. Invest. 31 (2001) 318-321
3. Boes E., Fliser D., Ritz E., Konig P., Lhotta K., Mann J.F., et al. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. J. Am. Soc. Nephrol. 17 (2006) 528-536
4. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., and Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37 (2006) 1503-1507
5. Bostom A.G., Kronenberg F., and Ritz E. Predicitive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J. Am. Soc. Nephrol. 13 (2002) 2140-2144
6. Briney W.G., Ogden D., Bartholomew B., and Smyth C.J. The influence of allopurinol on renal function in gout. Arthritis Rheum. 18 (1975) 877-881
7. Chonchol M., Shlipak M.G., Katz R., Sarnak M.J., Newman A.B., Siscovick D.S., et al. Relationship of uric acid with progression of kidney disease. Am. J. Kidney Dis. 50 (2007) 239-247
8. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283 (2000) 2404-2410
9. Fessel W.J. Renal outcomes of gout and hyperuricemia. Am. J. Med. 67 (1979) 74-82
10. Fliser D., Kollerits B., Neyer U., Ankerst D.K., Lhotta K., Lingenhel A., et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study. J. Am. Soc. Nephrol. 18 (2007) 2600-2608
11. Fliser D., Kronenberg F., Kielstein J.T., Morath C., Bode-Böger S.M., Haller H., et al. Asymmetric dimethylarginine and progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study. J. Am. Soc. Nephrol. 16 (2005) 2456-2461
12. Frohlich E.D. Uric acid. A risk factor for coronary heart disease. JAMA 270 (1993) 378-379
13. Hunsicker L.G., Adler S., Caggiula A., England B.K., Greene T., Kusek J.W., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 51 (1997) 1908-1919
14. Iseki K., Ikemiya Y., Inoue T., Iseki C., Kinjo K., and Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am. J. Kidney Dis. 44 (2004) 642-650
15. Iseki K., Oshiro S., Tozawa M., Iseki C., Ikemiya Y., and Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens. Res. 24 (2001) 691-697
16. Johnson R.J., Segal M.S., Srinivas T., Ejaz A., Mu W., Roncal C., et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?. J. Am. Soc. Nephrol. 16 (2005) 1909-1919
17. Jossa F., Farinaro E., Panico S., Krogh V., Celentano E., Galasso R., et al. Serum uric acid and hypertension: the Olivetti heart study. J. Hum. Hypertens. 8 (1994) 677-681
18. Kanbay M., Ozkara A., Selcoki Y., Isik B., Turgut F., Bavbek N., et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int. Urol. Nephrol (2007)
19. Kanellis J., Feig D.I., and Johnson R.J. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton) 9 (2004) 394-399
20. Kang D.H., Anderson S., Kim Y.G., Mazzalli M., Suga S., Jefferson J.A., et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am. J. Kidney Dis. 37 (2001) 601-611
21. Kang D.H., Nakagawa T., Feng L., Watanabe S., Han L., Mazzali M., et al. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 13 (2002) 2888-2897
22. Kollerits B., Fliser D., Heid I.M., Ritz E., and Kronenberg F. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int. 71 (2007) 1279-1286
23. Kronenberg F., Kuen E., Ritz E., Junker R., König P., Kraatz G., et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J. Am. Soc. Nephrol. 11 (2000) 105-115
24. Long D.A., Mu W., Price K.L., and Johnson R.J. Blood vessels and the aging kidney. Nephron Exp. Nephrol. 101 (2005) e95-e99
25. Masuo K., Kawaguchi H., Mikami H., Ogihara T., and Tuck M.L. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42 (2003) 474-480
26. Melk A., Schmidt B.M., Takeuchi O., Sawitzki B., Rayner D.C., and Halloran P.F. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65 (2004) 510-520
27. Nakagawa T., Kang D.H., Feig D., Sanchez-Lozada L.G., Srinivas T.R., Sautin Y., et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 69 (2006) 1722-1725
28. Nakagawa T., Mazzali M., Kang D.H., Kanellis J., Watanabe S., Sanchez-Lozada L.G., et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am. J. Nephrol. 23 (2003) 2-7
29. Nakanishi N., Okamoto M., Yoshida H., Matsuo Y., Suzuki K., and Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur. J. Epidemiol. 18 (2003) 523-530
30. Ohno I., Hosoya T., Gomi H., Ichida K., Okabe H., and Hikita M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87 (2001) 333-339
31. Perez-Ruiz F., Calabozo M., Herrero-Beites A.M., Garcia-Erauskin G., and Pijoan J.I. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86 (2000) 287-291
32. Rosenfeld J.B. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects. Adv. Exp. Med. Biol. 41 (1974) 581-596
33. Sanchez-Lozada L.G., Tapia E., Santamaria J., vila-Casado C., Soto V., Nepomuceno T., et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 67 (2005) 237-247
34. Siu Y.P., Leung K.T., Tong M.K., and Kwan T.H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am. J. Kidney Dis. 47 (2006) 51-59
35. Spanaus K.-S., Kronenberg F., Ritz E., Schlapbach R., Fliser D., Hersberger M., et al. B-type natriuretic peptide concentrations predict the progression of non-diabetic chronic kidney disease: The Mild-to-Moderate Kidney Disease Study. Clin. Chem. 53 (2007) 1264-1272
36. Syrjanen J., Mustonen J., and Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transpl. 15 (2000) 34-42
37. Tomita M., Mizuno S., Yamanaka H., Hosoda Y., Sakuma K., Matuoka Y., et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J. Epidemiol. 10 (2000) 403-409
38. Vaziri N.D., Freel R.W., and Hatch M. Effect of chronic experimental renal insufficiency on urate metabolism. J. Am. Soc. Nephrol. 6 (1995) 1313-1317
39. Yu T.F., and Berger L. Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease. Am. J. Med. 72 (1982) 95-100